Results 11 to 20 of about 22,604 (146)

In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection [PDF]

Journal of the Pediatric Infectious Diseases Society, 2020
Abstract Evidence for in utero transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is growing but not definitive. We present a case of neonatal infection that supports in utero transmission of SARS-CoV-2 and provides insight into the hematogenous spread from mother to fetus.
Peter D. Burbelo, Marcos J Ramos-Benitez, Julie Alejo, Stephen M. Hewitt, Isabelle Von Kohorn, Isabelle Von Kohorn, Daniel S. Chertow, David E. Kleiner, Sydney Stein, Kevin M. Vannella, Beatrix T Shikani, Bernhard L. Wiedermann, Jeffrey I. Cohen   +12 more
openaire   +2 more sources

Management of severe neonatal respiratory distress due to vertical transmission of severe acute respiratory syndrome coronavirus 2: a case report

Journal of Medical Case Reports, 2022
Background Neonates with severe acute respiratory syndrome coronavirus 2 infection are usually asymptomatic or have mild to moderate symptoms. Acute respiratory distress syndrome due to severe acute respiratory syndrome coronavirus 2 with respiratory ...
Anne C. Verheijen, Eva E. R. Janssen, Mayke E. van der Putten, Marieke W. P. van Horck, Gijs T. J. van Well, Inge H. M. Van Loo, Matthias C. Hütten, Karen Van Mechelen   +7 more
doaj   +1 more source

Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature

Journal of Medical Case Reports, 2021
Introduction We report a case of Severe acute respiratory syndrome coronavirus-2 infection with acute pancreatitis as the only presenting symptom. To the best of our knowledge, there are few case reports of the same presentation.
Abdullah S. Eldaly, Ayman R. Fath, Sarah M. Mashaly, Muhammed Elhadi   +3 more
doaj   +1 more source

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

PLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara   +6 more
doaj   +2 more sources

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

SAGE Open Medicine, 2022
Objectives: The severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019. A serological test is conducted to determine prior infection by severe acute respiratory syndrome coronavirus 2.
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, Shigeto Tohma   +6 more
doaj   +1 more source

Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview [PDF]

Head & Neck, 2020
AbstractThe novel coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was declared a pandemic in March 2020. A plethora of respiratory sampling methods for SARS‐CoV‐2 viral detection has been used and in the current evolving situation, there is no international consensus on the recommended method ...
See, Anna, Toh, Song Tar
openaire   +3 more sources

Determining Cause of Death During Coronavirus Disease 2019 Pandemic

Critical Care Explorations, 2021
Objectives:. Controversy exists whether the cause of death due to severe acute respiratory syndrome coronavirus 2 is directly related to the infection or to underlying conditions.
Khaled M. Nada, MD, En-shuo Hsu, MS, Justin Seashore, MD, Mohammed Zaidan, MD, Shawn P. Nishi, MD, Alexander Duarte, MD, Gulshan Sharma, MD, MPH   +6 more
doaj   +1 more source

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

Future Journal of Pharmaceutical Sciences, 2022
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar   +6 more
doaj   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2

, 2022
COVID-19, caused by SARS-CoV-2, is an emerging viral respiratory pathogen. The disease was first described in China in 2019, likely emerging as a zoonosis, before spreading worldwide to cause a severe global pandemic in 2020. COVID-19 is transmitted person to person, predominantly by droplet spread.
Catherine F Houlihan, Michael Marks, Melissa Heightman, Lucy C K Bell, Nicholas Hart, Geraldine O’Hara   +5 more
openaire   +2 more sources

A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

Cureus, 2020
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus strain that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. It spread to several countries across continents and infected more than one million people within three months. While there is no consensus on the treatment of the disease
Robert Hage, Ahmed Mahgoub, Soo-Yeon Sohn, Woong Kee Baek   +3 more
openaire   +3 more sources